Targeting bacterial central metabolism for drug development

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Current antibiotics target DNA replication, protein synthesis, and cell wall biosynthesis.
• Rising global antibiotic resistance necessitates novel therapeutic strategies.
• Bacterial central metabolic pathways represent an underexplored target space for new drugs.

Purpose of the Study:

• To review the potential of targeting bacterial central metabolism for novel antibiotic development.
• To address the complexities and feasibility of using central metabolic pathways as drug targets.
• To draw insights from oncology drug development for antibacterial strategies.

Main Methods:

• Literature review and synthesis of current research on bacterial metabolism and antibiotic resistance.
• Analysis of essentiality and context-dependency of central metabolic targets.
• Comparative study of strategies used in oncology for targeting metabolic pathways.

Main Results:

• Bacterial central metabolism presents a complex but promising target space for next-generation antibiotics.
• Target validation in central metabolism is challenging due to conditional essentiality.
• Lessons from oncology highlight potential strategies for targeting metabolic vulnerabilities.

Conclusions:

• Targeting bacterial central metabolism is a viable, albeit complex, strategy for developing new antibiotic classes.
• Further research is needed to overcome challenges in target validation and drug design.
• This approach offers a potential solution to the growing crisis of antimicrobial resistance.